Cumberland Pharmaceuticals (CPIX) FCF Margin (2010 - 2026)

Cumberland Pharmaceuticals has disclosed FCF Margin across 17 years of filings, most recently posting 4.24% for Q1 2026.

• FCF Margin for Q1 2026 came in at 4.24%, down 2864.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.27% (down 976.0% YoY), and the FY2025 annual result was 10.86%, up 1265.0% from the prior year.
• FCF Margin came in at 4.24% for Q1 2026 at Cumberland Pharmaceuticals, up from 0.02% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 47.42% in Q2 2023 to a low of 25.63% in Q1 2024.
• The 5-year median for FCF Margin is 7.54% (2025), against an average of 10.14%.
• Across the five-year window, FCF Margin tumbled 5618 bps in 2024 and soared 5851 bps in 2025, its largest moves.
• Cumberland Pharmaceuticals' FCF Margin stood at 41.56% in 2022, then tumbled by 74 bps to 10.6% in 2023, then jumped by 72 bps to 18.23% in 2024, then sank by 100 bps to 0.02% in 2025, then soared by 19066 bps to 4.24% in 2026.
• The last three FCF Margin figures came in at 4.24% (Q1 2026), 0.02% (Q4 2025), and 1.97% (Q3 2025), per Business Quant data.